AGAPE ATP CORPORATION Revenue from Related Parties
AGAPE ATP CORPORATION (ATPC) reported Revenue from Related Parties of $6.63 thousand for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-07-05.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2022-07-05
- AGAPE ATP CORPORATION revenue from related parties for the quarter ending 2020-12-31 was $4.41K, a 97.71% decline year-over-year.
- AGAPE ATP CORPORATION revenue from related parties for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- AGAPE ATP CORPORATION revenue from related parties for the quarter ending 2020-06-30 was $13.65K, a 96.56% decline year-over-year.
- AGAPE ATP CORPORATION revenue from related parties for the quarter ending 2019-12-31 was $192.63K.
- AGAPE ATP CORPORATION revenue from related parties for fiscal 2021 was $6.63K, a 63.32% decline from fiscal 2020.
- AGAPE ATP CORPORATION revenue from related parties for fiscal 2020 was $18.06K, a 98.60% decline from fiscal 2019.
- AGAPE ATP CORPORATION revenue from related parties for fiscal 2019 was $1.29M.
| Period end | Revenue from Related Parties 3 month | Revenue from Related Parties 6 month | Revenue from Related Parties 9 month | Revenue from Related Parties 12 month |
|---|---|---|---|---|
| 2021-12-31 | $6.63K 10-K/A · filed 2022-07-05 | |||
| 2020-12-31 | $4.41K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $4.41K derived: sum of 2 quarters · filed 2022-07-05 | $18.06K derived: sum of 3 quarters · filed 2022-07-05 | $18.06K 10-K/A · filed 2022-07-05 |
| 2020-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-07-05 | $13.65K derived: sum of 2 quarters · filed 2022-07-05 | $13.65K 10-Q/A · filed 2022-07-05 | |
| 2020-06-30 | $13.65K 10-Q · filed 2021-08-13 | $13.65K 10-Q · filed 2021-08-13 | ||
| 2019-12-31 | $192.63K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-31 | $429.36K 10-K · filed 2021-03-31 | $825.83K derived: sum of 3 quarters · filed 2021-03-31 | $1.29M 10-K · filed 2021-03-31 |
| 2019-09-30 | $236.74K 10-Q · filed 2020-11-16 | $633.21K derived: sum of 2 quarters · filed 2020-11-16 | $1.10M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $396.47K 10-Q · filed 2020-08-13 | $860.77K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |